Press release
AI in Clinical Trials Market Set to Reach $38.7 Billion by 2029 with 43% Yearly Growth
AI in Clinical Trials Global Market Report 2025
The increasing occurrences of persistent and contagious diseases are anticipated to fuel the expansion of the AI in clinical trials market. Persistent diseases, which are health conditions lasting for over three months and can potentially worsen over time, can be managed through the utilization of artificial intelligence in clinical trials for the development of various therapeutic drugs. For instance, as of June 2022, data released by Macmillan Cancer Support, a cancer charity located in the UK, revealed that the number of people living with cancer hit 3 million in 2022 and is estimated to increase to nearly 3.5 million by 2025 and then 4 million by 2030 in the UK. Furthermore, in August 2024, the UK Health Security Agency, a UK-based governing body, disclosed that 368 measles cases were reported in 2023 in England, marking an almost seven times increase from the 53 cases recorded in 2022. The West Midlands and London were responsible for 44% and 33% of these cases, respectively. Consequently, the escalating instances of persistent and communicable diseases are propelling the expansion of the AI in clinical trials market.
Get Your AI in Clinical Trials Market Report Here:
https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report
What Is the projected market size and growth rate for the ai in clinical trials market?
Recent years have seen a significant expansion in the market size of AI in clinical trials. The market is projected to surge from $6.57 billion in 2024 to $9.21 billion in 2025, boasting a compound annual growth rate (CAGR) of 40.2%. The growth in the past years is credited to factors including healthcare data accumulation, advancements in computing power, the FDA's support for AI, the popularity of wearable devices, and the development of early AI algorithms.
There is a prediction for enormous expansion in the market size of AI in clinical trials in the upcoming years, reaching $38.7 billion by the year 2029, with a compound annual growth rate (CAGR) of 43.2%. Factors contributing to this growth within the projected period include the merging of real-life data, AI-led patient enrolment, AI-generated biomarker detection, AI-enhanced trial design refinement, and persistent monitoring technology. Foreseen trends during this period feature federated learning strategies, AI usage in flexible trials, AI-assisted outcome projections, AI-guided medicine formulations, and AI-enabled reutilization of drugs.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11961&type=smp
What new trends are reshaping the ai in clinical trials market and its opportunities?
Progress in technology is a crucial trend gaining traction in the AI in clinical trials sector. Companies within this market are integrating novel technological advances to maintain their competitive edge. For example, in February 2023, US-based Lantern Pharma, a company specializing in clinical-stage oncology, launched its exclusive RADR artificial intelligence ('AI') and machine learning ('ML') platform. This platform aims to transform the cost, speed, and duration of cancer medication discovery and development. The focus of these RADR advancements will be on the further application of state-of-the-art AI and ML techniques to develop antibody-drug conjugates (ADCs). ADCs are exquisitely targeted antibodies used for cancer treatment, linked to potent anti-tumor small molecules.
What major market segments define the scope and growth of the ai in clinical trials market?
The AI in clinical trials market covered in this report is segmented -
1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Technology: Machine Learning, Deep Learning, Supervised Learning, Other Technologies
4) By Application: Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology Diseases, Other Applications
5) By End-User: Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users
Subsegments:
1) By Software: Clinical Trial Management Systems (CTMS), Data Analytics Software, Predictive Analytics Tools, Patient Recruitment And Retention Software, Real-World Evidence Platforms
2) By Services: Consulting Services, Data Management And Analysis Services, Training And Support Services, Regulatory Compliance Services
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11961
Which region dominates the ai in clinical trials market?
North America was the largest region in the AI in clinical trials market in 2024. The regions covered in the AI in clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which key market leaders are driving the ai in clinical trials industry growth?
Major companies operating in the AI in clinical trials market include Intel, The International Business Machines Corporation (IBM), Koninklijke Philips N.V., ConcertAI, Samaa Technologies, Owkin Inc., Numerate, Neuroute, AiCure, Ardigen, Unlearn AI, PathAI, Exscentia, Aitia Infotech Pvt Ltd., Euretos, VeriSIM Life, Envisagenics, NURITAs, BioSymetrics, BioAge Labs Inc, Trials.Ai, Pharmaseal, Caylx, IQVIA
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=11961&type=smp
What Is Covered In The AI in Clinical Trials Global Market Report?
• Market Size Forecast: Examine the ai in clinical trials market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the ai in clinical trials market for a structured understanding.
• Key Players Overview: Analyze major players in the ai in clinical trials market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the ai in clinical trials market.
• Segment Contributions: Evaluate how different segments drive overall growth in the ai in clinical trials market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the ai in clinical trials market.
• Industry Challenges: Identify potential risks and obstacles affecting the ai in clinical trials market.
• Competitive Landscape: Review strategic developments in the ai in clinical trials market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI in Clinical Trials Market Set to Reach $38.7 Billion by 2029 with 43% Yearly Growth here
News-ID: 3897371 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Trial
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period.
Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the…
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.
Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
…
Clinical Trial Logistics
Clinical Trial Logistics
16th to 17th May 2011, Marriott Regents Park, London, United Kingdom.
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials…
Clinical Trial Logistics
Announcing SMi's 5th annual…
Clinical Trial Logistics conference
16th and 17th May 2011, Central London, UK
www.smi-online.co.uk/2011logistics-london6.asp
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical…
